Illumina, Inc.
ILMN
Rangering i aksjer
#599
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Aksjekurs
$269.53
Markedsverdi
$40.70B
Endring (1 dag)
2.61%
Endring (1 år)
170.88%
Land
US
Handel Illumina, Inc. (ILMN)
Kategori
Healthcare
Antall utestående aksjer for Illumina, Inc. (ILMN)
Antall utestående aksjer per June 2026: 151.00M
Ifølge Illumina, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 151.00M. Ved slutten av December 2024 hadde selskapet 159.00M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Illumina, Inc. (ILMN) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 151.00M | -1.31% |
| 2025 | 153.00M | -3.77% |
| 2024 | 159.00M | 0.63% |
| 2023 | 158.00M | 5.33% |
| 2022 | 150.00M | 2.04% |
| 2021 | 147.00M | 0.00% |
| 2019 | 147.00M | 0.00% |
| 2018 | 147.00M | 0.68% |
| 2017 | 146.00M | -0.68% |
| 2016 | 147.00M | 1.38% |
| 2015 | 145.00M | 6.97% |
| 2014 | 135.55M | 8.38% |
| 2013 | 125.08M | 1.69% |
| 2012 | 123.00M | -0.32% |
| 2011 | 123.40M | -0.15% |
| 2010 | 123.58M | 0.35% |
| 2009 | 123.15M | 5.39% |
| 2008 | 116.86M | 7.89% |
| 2007 | 108.31M | 21.69% |
| 2006 | 89.00M | 10.85% |
| 2005 | 80.29M | 12.00% |
| 2004 | 71.69M | 12.28% |
| 2003 | 63.85M | 3.35% |
| 2002 | 61.78M | 3.84% |
| 2001 | 59.50M | 6.95% |
| 2000 | 55.63M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 145.70% |
US
|
|
| 705.30M | 367.09% |
US
|
|
| 143.28M | -5.11% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 86.75% |
US
|
